Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy against Systemic Fungal Infections Based on Monoclonal Antibodies
Camila Boniche-Alfaro, Suélen Andreia Rossi, Brenda Kischkel, et al.
Journal of Fungi (2020) Vol. 6, Iss. 1, pp. 31-31
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Functionalized niosomes as a smart delivery device in cancer and fungal infection
Priyadarshi Aparajay, Abhimanyu Dev
European Journal of Pharmaceutical Sciences (2021) Vol. 168, pp. 106052-106052
Open Access | Times Cited: 97
Immunotherapies against human bacterial and fungal infectious diseases: A review
Hafsa Qadri, Abdul Haseeb Shah, Mustfa Alkhanani, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 24
Diagnosis and Treatment of Pulmonary Coccidioidomycosis and Paracoccidioidomycosis
Paula M. Peçanha‐Pietrobom, Andrés Tirado‐Sánchez, Sarah Santos Gonçalves, et al.
Journal of Fungi (2023) Vol. 9, Iss. 2, pp. 218-218
Open Access | Times Cited: 17
The microbial damage and host response framework: lesson learned from pathogenic survival trajectories and immunoinflammatory responses of Talaromyces marneffei infection
Kritsada Pruksaphon, Artid Amsri, Juthatip Jeenkeawpieam, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts
Steven T. Denham, Morgan A. Wambaugh, Jessica C. S. Brown
Journal of Molecular Biology (2019) Vol. 431, Iss. 16, pp. 2982-3009
Open Access | Times Cited: 43
Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
Moisés Morais Inácio, André Luís Elias Moreira, Vanessa Rafaela Milhomem Cruz-Leite, et al.
Journal of Fungi (2023) Vol. 9, Iss. 6, pp. 633-633
Open Access | Times Cited: 16
The evolution of antifungal therapy: traditional agents, current challenges and future perspectives
Cássia Milena de Souza, Bárbara Tavares Bezerra, Daniel Agreda Mellon, et al.
Current Research in Microbial Sciences (2025) Vol. 8, pp. 100341-100341
Open Access
Three new asexual Kirschsteiniothelia species from Guizhou Province, China
Xing-Juan Xiao, Ning-Guo Liu, Jian Ma, et al.
MycoKeys (2025) Vol. 113, pp. 147-168
Open Access
Biosimilars Targeting Pathogens: A Comprehensive Review of Their Role in Bacterial, Fungal, Parasitic, and Viral Infections
Mohamed Reda Halawa, Ramez M. Rashad ElSayed, Tope Aderibigbe, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 581-581
Open Access
Advances in Fungal Peptide Vaccines
Leandro B. R. da Silva, Carlos P. Taborda, Joshua D. Nosanchuk
Journal of Fungi (2020) Vol. 6, Iss. 3, pp. 119-119
Open Access | Times Cited: 30
Immunomodulation for the Treatment of Fungal Infections: Opportunities and Challenges
Muluneh Ademe
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 28
Antimicrobial peptide AMP-17 exerts anti–Candida albicans effects through ROS-mediated apoptosis and necrosis
Huiling Ma, Longbing Yang, Zhuqing Tian, et al.
International Microbiology (2022) Vol. 26, Iss. 1, pp. 81-90
Closed Access | Times Cited: 16
Vaccine development for pathogenic fungi: current status and future directions
Jéssica Luana Chechi, Felipe A. C. da Costa, J. Figueiredo, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 1136-1153
Open Access | Times Cited: 8
Novel avenues for identification of new antifungal drugs and current challenges
Josef Jampílek
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 9, pp. 949-968
Closed Access | Times Cited: 12
Novel targets and improved immunotherapeutic techniques with an emphasis on antimycosal drug resistance for the treatment and management of mycosis
Riya Sarkar, Krishnendu Adhikary, Arundhati Banerjee, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35835-e35835
Open Access | Times Cited: 2
Antibacterial and Antifungal Pyrazoles Based on Different Construction Strategies
Muneeb Ur Rehman, Fang He, Xi Shu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117081-117081
Closed Access | Times Cited: 2
Synthetic carbohydrate based anti-fungal vaccines
Vadim B. Krylov, Nikolay E. Nifantiev
Drug Discovery Today Technologies (2020) Vol. 35-36, pp. 35-43
Closed Access | Times Cited: 18
COVID-19-associated mucormycosis and treatments
Vetriselvan Subramaniyan, Neeraj Kumar Fuloria, Hari Kumar Darnal, et al.
Asian Pacific Journal of Tropical Medicine (2021) Vol. 14, Iss. 9, pp. 401-409
Open Access | Times Cited: 15
Crinum jagus (J. Thomps. Dandy): Antioxidant and protective properties as a medicinal plant on toluene-induced oxidative stress damages in liver and kidney of rats
Mustapha Salihu, Gaber El‐Saber Batiha, Keneth Iceland Kasozi, et al.
Toxicology Reports (2022) Vol. 9, pp. 699-712
Open Access | Times Cited: 11
The prophylactic effects of monoclonal antibodies targeting the cell wall Pmt4 protein epitopes of Candida albicans in a murine model of invasive candidiasis
Xiaojuan Wang, Peng Liu, Yuanying Jiang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 10
Production of IgY against iron permease Ftr1 from Candida albicans and evaluation of its antifungal activity using Galleria mellonella as a model of systemic infection
Patrícia Canteri de Souza, Alana Elke do Nascimento Corrêa, Juliana Gutschow Gameiro, et al.
Microbial Pathogenesis (2023) Vol. 181, pp. 106166-106166
Closed Access | Times Cited: 6
The Pathogenesis of Aspergillus fumigatus, Host Defense Mechanisms, and the Development of AFMP4 Antigen as a Vaccine
Xiang Gu, Yanhong Hua, Yang-Dong Zhang, et al.
Polish Journal of Microbiology (2021) Vol. 70, Iss. 1, pp. 3-11
Open Access | Times Cited: 13
Characteristics and potential clinical applications of the extracellular vesicles of human pathogenic Fungi
Habib Ullah, Yiyi Huang, Kening Zhao, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Monoclonal Antibodies Targeting Surface-Exposed Epitopes of Candida albicans Cell Wall Proteins Confer In Vivo Protection in an Infection Model
Soumya Palliyil, Mark Mawer, Sami A. Alawfi, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 4
Open Access | Times Cited: 8
Cryptococcus neoformans infections: aspartyl protease potential to improve outcome in susceptible hosts
Frédérique Vernel-Pauillac, Christine Laurent‐Winter, Laurence Fiette, et al.
mBio (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top